Manufacturing and Automation Research Center, Mechanical Engineering Department, Koc University, Istanbul, Turkey.
Artif Organs. 2011 Jul;35(7):720-5. doi: 10.1111/j.1525-1594.2010.01167.x. Epub 2011 Mar 1.
A prototype of a new implantable centrifugal blood pump system named Heart Turcica Centrifugal (HTC) was developed as a left ventricular assist device (LVAD) for the treatment of end-stage cardiac failure. In the development of HTC, effects of blade height and volute tongue profiles on the hydraulic and hemolytic performances of the pump were investigated. As a result, the prototype was manufactured using the best blade height and volute tongue profiles. Performance of the prototype model was experimentally evaluated in a closed-loop flow system using water as the medium. The hydraulic performance requirement of an LVAD (5 L/min flow rate against a pressure difference of 100 mm Hg) was attained at 2800 rpm rotational speed.
一种名为 Heart Turcica Centrifugal(HTC)的新型植入式离心泵系统原型被开发为左心室辅助装置(LVAD),用于治疗终末期心力衰竭。在 HTC 的开发过程中,研究了叶片高度和蜗壳舌形对泵的水力和溶血性能的影响。结果,使用最佳的叶片高度和蜗壳舌形制造了原型。使用水作为介质,在闭环流量系统中对原型模型的性能进行了实验评估。在 2800rpm 的转速下,原型模型达到了 LVAD 的水力性能要求(流量为 5L/min,压差为 100mmHg)。